Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nanog transforms NIH3T3 cells and targets cell-type restricted genes.

Dan Piestun1, Bose S Kochupurakkal, Jasmine Jacob-Hirsch

  • 1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.

Biochemical and Biophysical Research Communications
|March 17, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

A Phase Ib Study of Sapacitabine and Olaparib in Patients with BRCA1/2-Mutated Metastatic Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

BRAF mutations and targeted therapy in unclassified pericytic tumors: insights from genetic analysis and clinical response.

BMC cancer·2025
Same author

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation.

Molecular oncology·2025
Same author

A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Genotoxicity Associated with Retroviral CAR Transduction of ATM-Deficient T Cells.

Blood cancer discovery·2024

The transcription factor Nanog, crucial for embryonic stem cell self-renewal, can induce cell transformation and possesses oncogenic potential. Its expression in NIH3T3 cells promoted growth and a transformed phenotype, suggesting a link to germ cell tumors.

Area of Science:

  • * Stem cell biology
  • * Cancer research
  • * Molecular biology

Background:

  • * Nanog is a transcription factor essential for embryonic stem (ES) cell self-renewal.
  • * Nanog is also uniquely expressed in germ cell tumors, suggesting a role in cell transformation.
  • * The precise oncogenic potential and regulatory network of Nanog remain incompletely understood.

Purpose of the Study:

  • * To investigate the oncogenic potential of Nanog by expressing it in NIH3T3 cells.
  • * To identify Nanog-regulated genes and understand its transcriptional targets.
  • * To explore the relationship between Nanog's role in ES cell self-renewal and cell transformation.

Main Methods:

  • * Expression of Nanog in NIH3T3 cells.
  • * Assessment of cell proliferation and transformed phenotype (foci formation, soft agar colony growth).

Related Experiment Videos

  • * Microarray analysis to identify Nanog-regulated genes and ChIP-based validation of direct targets in ES cells.

    • Main Results:

    • * NIH3T3 cells expressing Nanog exhibited increased growth rates and a transformed phenotype.
    • * Nanog regulates distinct sets of genes in different cell types.
    • * Over 10% of Nanog-regulated genes are direct targets, with some potentially explaining NIH3T3 cell transformation.

    Conclusions:

    • * Nanog possesses oncogenic potential, contributing to cell transformation.
    • * Nanog's function in self-renewal and its role in germ cell tumors are linked to its oncogenic properties.
    • * Identification of Nanog target genes provides insights into the mechanisms of cell transformation.